Anaplastic giant cell lymphoma (ALCL), an aggressive CD30-positive T-cell lymphoma, contains systemic anaplastic lymphoma kinase (ALK)-positive, and ALK-negative, main cutaneous and breast implant-associated ALCL. Prognosis of some ALCL subgroups remains to be unsatisfactory, and already in second line efficient remedy choices are missing. To establish genes defining ALCL cell state and dependencies, we right...
